CLN13 disease

CLN13 disease, also known as adult-onset neuronal ceroid lipofuscinosis type 13 or Kufs disease type B (cathepsin F type), is an extremely rare inherited brain disorder. It belongs to a group of conditions called neuronal ceroid lipofuscinoses (NCLs), sometimes referred to as Batten disease. In CLN13 disease, the body cannot properly break down certain waste materials inside cells, leading to a buildup of fatty substances called lipofuscins in the brain and other tissues. This buildup gradually damages nerve cells over time. Symptoms typically begin in adulthood, usually between the ages of 20 and 40. The disease mainly affects the brain and nervous system, causing progressive problems with movement, thinking, and behavior. People may first notice difficulty with coordination, tremors, or changes in personality and mood. Over time, cognitive decline (dementia), seizures, speech difficulties, and movement problems such as stiffness or involuntary movements can develop. Vision is usually preserved in this form, which helps distinguish it from childhood-onset forms of NCL. There is currently no cure for CLN13 disease. Treatment focuses on managing symptoms, such as using anti-seizure medications to control epilepsy and providing supportive therapies like physical therapy, occupational therapy, and speech therapy. The disease is progressive, meaning symptoms worsen over time. Research into potential therapies, including gene therapy and enzyme replacement, is ongoing for the broader group of NCL disorders, but no disease-modifying treatment is yet available for CLN13 specifically.

Bring these to your next appointment

• Q1.What stage of CLN13 disease am I in, and what symptoms should I expect next?,What medications are best for managing my seizures, and what are the side effects?,Are there any clinical trials or research studies I could participate in?,How often should I have follow-up appointments and brain imaging?,What therapies (physical, occupational, speech) would benefit me most right now?,Should my family members be tested for the CTSF gene mutation?,What resources or support services are available for me and my family?

Common questions about CLN13 disease